Article
PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.
PloS one - 1 Jan 2018
Kruk Beata, Liebe Roman, Milkiewicz Małgorzata, Wunsch Ewa, Raszeja-Wyszomirska Joanna, Lammert Frank, Milkiewicz Piotr, Krawczyk Marcin
Abstract excerpt
BACKGROUND: The adiponutrin (PNPLA3) p.I148M and transmembrane 6 superfamily member 2 (TM6SF2) p.E167K variants represent major genetic risk factors for progressive liver injury in nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD) and chronic viral hepatitis. The aim of this study was to find out whether these variants have a detrimental impact on the progression of chronic liver disease in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
